Comparison of Matched-Sibling Donors Versus Unrelated Donors in Allogeneic Stem Cell Transplantation (allo-SCT) for Primary Refractory Acute Myeloid Leukemia (PRF AML): A Report of 1041 Patients from the Acute Leukemia Working Party of the EBMT

被引：0

作者：

Brissot, Eolia ^{[1
]}

Labopin, Myriam ^{[2
]}

Stelljes, Matthias ^{[3
]}

Ehninger, Gerhard ^{[4
]}

Stuhler, Gernot ^{[5
]}

Finke, Jurgen ^{[6
]}

Kolb, Hans Jochem ^{[7
]}

Ganser, Arnold ^{[8
]}

Schaefer-Eckart, Kerstin ^{[9
]}

Kroeger, Nicolaus ^{[10
]}

Bunjes, Donald ^{[11
]}

Mielke, Stephan ^{[12
]}

Bethge, Wolfgang ^{[13
]}

Tabrizi, Reza ^{[14
]}

Peter, Kalhs ^{[15
]}

Blau, Igor W. ^{[16
]}

Glass, Bertran ^{[17
]}

Vitek, Antonin ^{[18
]}

Gramatzki, Martin ^{[19
]}

Holler, Ernst ^{[20
]}

Schmid, Christoph ^{[21
]}

Esteve, Jordi ^{[22
]}

Nagler, Arnon ^{[23
,24
,25
,26
]}

Mohty, Mohamad ^{[27
]}

机构：

[1] Hop St Antoine, Serv Hematol & Therapie Cellulaire, F-75571 Paris, France

[2] St Antoine Hosp, Dept Hematol & Cell Therapy, Paris, France

[3] Univ Munster, Dept Med Hematol & Oncol A, D-48149 Munster, Germany

[4] Univ Hosp TU Dresden, Dept Med 1, Dresden, Germany

[5] DKD Helios Klin Wiesbaden, Zentrum Blutstammzell & Knochenmarktransplantat, Wiesbaden, Germany

[6] Univ Freiburg, Hematol Oncol & Stem Cell Transplantat, D-79106 Freiburg, Germany

[7] Univ Munich, Dept Hernatopoet Transplantat, MED3, Munich, Germany

[8] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany

[9] Klinikum Nuernberg, Dept Hematol & Oncol, Nurnberg, Germany

[10] Univ Hamburg Hosp, Dept Stem Cell Transplantat, Hamburg, Germany

[11] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany

[12] Univ Klinikum Wurzburg, Abt Hamatol & Onkol, Zentrum Innere Med, Wurzburg, Germany

[13] Univ Tubingen, Dept Hematol & Oncol, Tubingen, Germany

[14] Univ Hosp Bordeaux, Hematol, Pessac, France

[15] Med Univ Vienna, Dept Internal Med 1, Bone Marrow Transplantat Unit, Vienna, Austria

[16] Charite Campus Benjamin Franklin, Dept Internal Med 3, Berlin, Germany

[17] 2AsklepiosKlin St Georg, Abt Hamatol & Stammzelltransplantat, Hamburg, Germany

[18] Inst Hematol & Blood Transfus, Dept Hematol, CR-12820 Prague, Czech Republic

[19] Univ Hosp Schleswig Holstein, Div Stem Cell Transplantat & Immunotherapy, Dept Med, Kiel, Germany

[20] Klinikum Univ Regensburg, Abt Hamatol Intern Onkol, Regensburg, Germany

[21] Klinikum Augsburg, Med Klin 2, Augsburg, Germany

[22] Hosp Clin Barcelona, Spanish MDS Cooperat Grp, Barcelona, Spain

[23] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel

[24] EBMT Acute Leukemia Working Party, Tel Hashomer, Israel

[25] Chaim Sheba Med Ctr, Paris, Israel

[26] EBMT Acute Leukemia Working Party, Paris, Israel

[27] Univ Paris 06, St Antoine Hosp, AP HP, Dept Hematol, Paris, France

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[31] Factors determining the Kinetics of Disease Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukaemia (AML): a survey from the Acute Leukaemia Working Party of the EBMT
Craddock, C.
Labopin, M.
Socie, G.
Huyn, A.
Deconinck, E.
Volin, L.
Milpied, N.
Bourhis, J. -H.
Rambaldi, A.
Chevallier, P.
Cornelissen, J.
Blaise, D.
Maertens, J.
Schmid, C.
Nagler, A.
Mohty, M.
[J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S82 - S83
[32] Reduced Intensity Versus Conventional Myeloablative Conditioning (RIC vs. MAC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Lymphoblastic Leukemia (ALL): A Survey from the Acute Leukemia Working Party of EBMT
Mohty, Mohamad
Labopin, Myriam
Ruutu, Tapani
Gratwohl, Alois
Socie, Gerard
Esteve, Jordi
Tabrizi, Reza
Nagler, Arnon
Rocha, Vanderson
[J]. BLOOD, 2008, 112 (11) : 294 - 295
[33] Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT
Poire, Xavier
Labopin, Myriam
Polge, Emmanuelle
Forcade, Edouard
Ganser, Arnold
Volin, Liisa
Michallet, Mauricette
Blaise, Didier
Yakoub-Agha, Ibrahim
Maertens, Johan
Richard Espiga, Carlos
Cornelissen, Jan
Finke, Jurgen
Mohty, Mohamad
Esteve, Jordi
Nagler, Arnon
[J]. HAEMATOLOGICA, 2020, 105 (02) : 414 - 423
[34] The role of reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML): A donor versus no donor comparison.
Mohty, M
de Lavallade, H
Faucher, C
Vey, N
Gastaut, JA
Blaise, D
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 570S - 570S
[35] Comparison of Matched/Mismatched Unrelated Donor Stem Cell Transplantation to Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: A Study from the Acute Leukemia Working Party of the EBMT
Saraceni, F.
Labopin, M.
Gorin, N. -C.
Blaise, D.
Tabrizi, R.
Volin, L.
Cornelissen, J.
Cahn, J. -Y.
Chevallier, P.
Craddock, C.
Depei, W.
Huynh, A.
Arcese, W.
Mohty, M.
Nagler, A.
[J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S7 - S8
[36] Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical Sibling Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT
Battipaglia, Giorgia
Labopin, Myriam
Hamladji, Rose-Marie
Blaise, Didier
Chevallier, Patrice
Gerbitz, Armin
Socie, Gerard
Afanasyev, Boris
Ciceri, Fabio
Meijer, Ellen
Koc, Yener
Cornelissen, Jan J.
Huynh, Anne
Ozdogu, Hakan
Maertens, Johan
Paul, Franciane
Labussiere-Wallet, Helene
Aljurf, Mahmoud
Bazarbachi, Ali
Savani, Bipin N.
Nagler, Arnon
Mohty, Mohamad
[J]. BLOOD, 2019, 134
[37] The role of reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (ALLO-SCT) in patients with acute myeloid leukemia (AML): A donor versus no donor comparison
De Lavallade, H
Mohty, M
Faucher, C
Vey, N
Coso, D
Stoppa, AM
Gastaut, JA
Ladaique, P
Chabannon, C
Blaise, D
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 3 - 3
[38] Allogeneic stem cell transplantation (allo-SCT) in patients with advanced-phase acute leukemia
Michalakeas, I
Baltathakis, I
Karakasis, D
Delistrati, V
Poulopoulou, Z
Bika, E
Skandalis, A
Harhalakis, N
Nikiforakis, E
[J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S81 - S81
[39] Trends in allogeneic stem cell transplantation outcomes for acute myeloid Leukemia patients. The experience of the Acute Leukemia Working Party of the EBMT
Canaani, Jonathan
Beohou, Eric
Labopidn, Myriam
Ghavamzadeh, Ardeshir
Beelen, Dietrich
Hamladji, Rose-Marie
Niederwieser, Dietger
Volin, Liisa
Markiewicz, Miroslaw
Arnold, Renate
Mufti, Ghulam
Ehninger, Gerhard
Socie, Gerard
Kroeger, Nicolaus
Mohty, Mohamad
Nagler, Arnon
[J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 26 - 27
[40] Contrasting Factors Determine the Kinetics of Disease Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukaemia (AML): a Survey from the Acute Leukaemia Working Party of the EBMT
Craddock, Charles
Labopin, Myriam
Socie, Gerard
Huyn, Anne
Deconinck, Eric
Volin, Liisa
Milpied, Noel
Bourhis, Jean-Henri
Rambaldi, Alessandro
Chevallier, Patrice
Cornelissen, Jan J.
Blaise, Didier
Maertens, Johann
Schmid, Christoph
Nagler, Arnon
Mohty, Mohamad
[J]. BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →